Federal health officials will no longer routinely approve annual COVID-19 shots for younger adults and children who are ...

Late-stage trial data suggest that a new COVID-flu vaccine offers good protection against both infections, but experts expect ...

The vaccine, Nuvaxovid, is the third coronavirus shot to gain full approval, joining vaccines from Pfizer and Moderna. It has ...

After a six-week delay, the US Food and Drug Administration has approved Novavax’s Covid-19 vaccine, according to a letter ...

The agency narrowed who can get the shot and added new study requirements that could cost the company tens of millions.

The U.S. Food and Drug Administration approved Novavax's COVIDd-19 vaccine with age restrictions after a six-week delay.

This vaccine did previously have emergency approval by the FDA for use but can now be marketed in the U.S. for use, the ...

China on Sunday announced anti-dumping duties as high as 74.9% on imports of POM copolymers, a type of engineering plastic, ...

Novavax shares surged more than 17% before the bell on Monday, following the long-delayed approval of its COVID-19 vaccine ...

In its Friday approval letter, the FDA didn’t explain the restrictions although they reflect skepticism about ...

The Food and Drug Administration unveiled plans Tuesday to narrow its approval for updated coronavirus vaccines to older ...

The FDA announced it will limit access to Covid-19 vaccines going forward to people 65 and older and others at high risk of ...